Aquatic ecotoxicology of fluoxetine

Toxicology Letters

Volumn 142, Issue 3, 2003, Pages 169-183

  Brooks, Bryan W ^a,e   Foran, Christy M ^b   Richards, Sean M ^c,f   Weston, James ^d   Turner, Philip K ^a   Stanley, Jacob K ^a   Solomon, Keith R ^c   Slattery, Marc ^d   La Point, Thomas W ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF GUELPH   (Canada)

^d UNIVERSITY OF MISSISSIPPI   (United States)

^e BAYLOR UNIVERSITY   (United States)

^f UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

Author keywords

Environmental pharmaceuticals; Fluoxetine; Risk assessment; Serotonin reuptake inhibitor

Indexed keywords

FLUOXETINE; SURFACE WATER;

ANIMAL REPRODUCTIVE PROCEDURES; AQUATIC ENVIRONMENT; ARTICLE; CONTROLLED STUDY; CYPRINODONTIFORMES; ECOTOXICOLOGY; ENDOCRINE FUNCTION; HAZARD; MATHEMATICAL COMPUTING; MESOCOSM; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TOXICITY TESTING;

CELLULAR ORGANISMS; ORYZIAS; ORYZIAS LATIPES;

EID: 0345701334     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(03)00066-3     Document Type: Article

References (91)

1. Arcand-Hoy L.D., Benson W.H. Toxic responses of the reproductive system. Schlenk D., Benson W.H. Target Organ Toxicity in Marine and Freshwater Teleosts: Systems. II:2001;Taylor and Francis, New York.
2. Arcand-Hoy L.D., Nimrod A.C., Benson W.H. Endocrine-modulating substances in the environment: estrogenic effects of pharmaceutical products. Int. J. Toxicol. 17:1998;139-158.
3. Azmitia E.C. Serotonin neurons, neuroplasticity, and homeostatsis of neural tissue. Neuropsychopharmacology. 21:(Suppl. 1):1999;33S-45.
4. Boudou A., Ribeyre F. Aquatic ecotoxicology from the ecosystem to the cellular and molecular levels. Environ. Health Perspect. 105:(Suppl. 1):1997;21-35.
5. Brooks B.W., Chambers J.A., Libman B.S., Threlkeld S.T. Main and interactive effects in a wetland mesocosm experiment: algal community responses to agrichemical runoff. Proc. Miss. Water Resour. 27:1997;111-118.
6. Brooks, B.W., Turner, P.K., Stanley, J.K., Weston, J., Glidewell, E.A., Foran, C.M., Slattery, M., La Point, T.W., Huggett, D.B., 2003a. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere (in press).
7. Brooks, B.W., Dzialowski, E.M., Turner, P.K., Stanley, J.K., Glidewell, E.A., 2003b. Pharmaceutical effects on freshwater invertebrates. Annual Meeting of the American Society of Limnology and Oceanography, Salt Lake City, UT.
8. Bruce R.D., Versteeg D.J. A statistical procedure for modeling continuous toxicity data. Environ. Toxicol. Chem. 11:1992;1485-1494.
9. Buser H.-R., Muller M.D. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 32:1998;188-192.
10. Buser H.-R., Poiger T., Muller M.D. Occurance and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 33:1999;2529-2535.
11. Cairns J. Jr. Are single species toxicity tests alone adequate for estimating environmental hazard? Hydrobiology. 100:1983;47-57.
12. Cairns J. Jr. The myth of the most sensitive species. BioScience. 36:1986;670-672.
13. Canadian Pharmacists Association, 2000. In: Welbanks, L. (Ed.), Compendium of Pharmaceuticals and Specialties. Canadian Pharmacists Association, Toronto.
14. Cerda J., Subhoder N., Reich G., Wallace R.A., Selman K. Oocyte sensitivity to serotonergic regulation during the follicular cycle of the teleost Fundulus heteroclitus. Biol. Reprod. 59:1998;53-61.
15. CNN, 2001. FDA Clears 'generic Prozac' For Sale. CNN.com/Health, August 2, 2001. http://www.cnn.com/2001/HEALTH/08/01/prozac.barr/ (cited 23 June 2002).
16. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 107:(6):1999;907-938.
17. Dickson K.L., Waller W.T., Kennedy J.H., Arnold W.R., Desmond W.P., Dyer S.D., Hall J.F., Knight J.T. Jr, Malas D., Martinez M.L., Matzner S.L. A Water Quality and Ecological Survey of the Trinity River. I and II:1989;City of Dallas Water Utilities, Dallas, TX.
18. Dickson K.L., Waller W.T., Kennedy J.H., Ammann L.P. Assessing the relationship between ambient toxicity and instream biological response. Environ. Toxicol. Chem. 11:1992;1307-1322.
19. Dickson K.L., Waller W.T., Kennedy J.H., Ammann L.P., Guinn R., Norberg-King T.J. Relationships between effluent toxicity, ambient toxicity, and receiving systems impacts: Trinity River dechlorination case study. Grothe D.R., Dickson K.L., Reed-Judkins D.K. Whole Effluent Toxicity Testing: An Evaluation of Methods and Prediction of Receiving System Impacts. 1996;SETAC Press, Pensacola, FL.
20. Dorn P.B. An industrial perspective on whole effluent toxicity testing. Grothe D.R., Dickson K.L., Reed-Judkins D.K. Whole Effluent Toxicity Testing: An Evaluation of Methods and Prediction of Receiving System Impacts. 1996;SETAC Press, Pensacola, FL.
21. Eugen-Olsen J., Afzelius P., Andresen L., Iversen J., Kronborg G., Aabech P., Nielsen J.O., Hofmann B. Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin. Immunol. Immunopathol. 84:1997;115-121.
22. FDA-CDER, 1996. Retrospective review of ecotoxicity data submitted in environmental assessments. FDA Center for Drug Evaluation and Research, Rockville, MD. Docket no. 96N-0057.
23. FDA-CDER, 1998. Guidance for industry - environmental assessment of human drugs and biologics applications, Revision 1. FDA Center for Drug Evaluation and Research, Rockville, MD. (http://www.fda.gov/cder/guidance/1730fnl.pdf, cited 23 June 2002).
24. Flaherty, C.M., Kashian, D.R., Dodson, S.I., 2001. Ecological impacts of pharmaceuticals on zooplankton: the effects of three medications on Daphnia magna. Annual Meeting of the Society of Environmental Toxicology and Chemistry, Baltimore, MD.
25. Fong P.P. Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol. Bull. 194:(2):1998;143-149.
26. Fong P.P. Antidepressants in aquatic organisms: a wide range of effects. Daughton C.G., Jones-Lepp T.L. Pharmacueticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. 2001;264-281 American Chemical Society, Washington, D.C.
27. Fong P., Huminski P., D'Urso L. Induction and potentiation of parturition in fingernail clams by selective serotonin re-uptake inhibitors. J. Exp. Zool. 280:1998;260-264.
28. Foran C.M., Peterson B.N., Benson W.H. Transgenerational and developmental exposure of Japanese medaka (Oryzias latipes) to ethinylestradiol results in endocrine and reproductive differences in the response to ethinylestradiol as adults. Toxicol. Sci. 68:2002;389-402.
29. Golet E.M., Alder A.C., Hartmann A., Ternes T.A., Giger W. Trace determination of fluoroquinolone antibacterial agents in solid-phase extraction urban wastewater by and liquid chromatography with fluorescence detection. Anal. Chem. 73:(15):2001;3632-3638.
30. Guarino A.M., Lech J.J. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species. Vet. Hum. Toxicol. 28:(Suppl. 1):1986;38-44.
31. Halling-Sorensen B., Nors-Nielsen S., Lanzky P.F., Ingerslev F., Holten-Lutzhoft H.C., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere. 36:(2):1998;357-393.
32. Hamilton M.A., Russo R.C., Thurston R.V. Trimmed Spearman-Kaber method for estimating median lethal concentrations in toxicity bioassays. Environ. Sci. Technol. 11:1977;714-719. Correction 12, 417 (1978).
33. Harries J., Sheahan D., Jobling S., Matthiessen P., Neall P., Sumpter J., Tylor T., Zaman N. Estrogenic activity in five United Kingdom rivers detected by measurement of vitellogenesis in caged male trout. Environ. Toxicol. Chem. 16:1997;534-542.
34. Hart, A. (Ed.), 2001. Probabilistic Risk Assessment for Pesticides in Europe: Implementation and Research Needs. Central Science Laboratory, Sand Hutton, York, UK.
35. Hemming J.M., Waller W.T., Chow M.C., Denslow N.D., Venables B. Assessment of the estrogenicity and toxicity of a domestic wastewater effluent flowing through a constructed wetland system using biomarkers in male fathead minnow (Pimephales promelas Rafinesque, 1820). Environ. Toxicol. Chem. 20:2001;2268-2275.
36. Hemming J.M., Turner P.K., Brooks B.W., Waller W.T., La Point T.W. Assessment of toxicity reduction in wastewater effluent flowing through a treatment wetland using Pimephales promelas, Ceriodaphnia dubia, and Vibrio fischeri. Arch. Environ. Contam. Toxicol. 42:2002;9-16.
37. Hernandez-Rauda R., Rozas G., Rozas G., Rey P., Otero J., Aldegunde M. Changes in the pituitary metabolism of monoamines (dopamine, norepinephrine, and serotonin) in female and male rainbow trout (Oncorhynchus mykiss) during gonadal recrudescence. Physiol. Biochem. Zool. 72:1999;352-359.
38. Hiemke C., Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 85:2000;11-28.
39. Hill, I.R., Heimbach, F., Leeuwangh, P., Matthiessen, P. (Eds.), 1994. Freshwater Field Tests for Hazard Assessment of Chemicals. CRC Press, Boca Raton FL.
40. Hindberg I., Naesh O. Serotonin concentrations in plasma and variations during the menstrual cycle. Clin. Chem. 38:1992;2087-2089.
41. Hirsch R., Ternes T., Haberer K., Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225:(1-2):1999;109-118.
42. Hofmann B., Afzelius P., Iversen J., Kronborg G., Aabech P., Benfield T., Dybkjaer E., Nielsen J.O. Buspirone, a serotonin receptor agonist, increases CD4 T-cell counts and modulates the immune system in HIV-seropositive subjects. AIDS. 10:1996;1339-1347.
43. Honkoop P.J.C., Luttikhuizen P.C., Piersma T. Experimentally extending the spawning season of a marine bivalve using temperature change and fluoxetine as synergistic triggers. Mar. Ecol. Prog. Ser. 180:1999;297-300.
44. Huber R., Delago A. Serotonin alters decisions to withdraw in fighting crayfish, Astacus astacus: the motivational concept revisited. J. Comp. Phys. A. 182:(5):1998;573-583.
45. Huggett D., Khan I., Foran C., Schlenk D. Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ. Pollut. 121:2003;199-205.
46. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., Schlenk D. Toxicity of select beta-adrenergic receptor blocking pharmacueticals (β-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 43:2002;229-235.
47. Iwamatsu T., Toya Y., Sakai N., Yasutaka T., Nagata R., Nagahama Y. Effect of 5-hyroxytryptamine on steroidogenesis and oocytye maturation in pre-ovulatory follicles of the medaka Oryzias latipes. Dev. Growth Differ. 35:1993;625-630.
48. Jones-Lepp, T.L., Alvarez, D.A., Petty, J.D., Osemwengie, L.I., Daughton, C.G., 2001. Analytical chemistry for mapping trends of pharmaceutical and personal care product pollution from personal use: some current research and future needs. 10th Symposium on Handling of Environmental and Biological Samples in Chromatography, Mainz/Wiesbaden, Germany.
49. Kennedy J.H., La Point T.W., Balci P., Stanley J., Johnson Z.B. Model aquatic ecosystems in ecotoxicological research: considerations of design, implementation, and analysis. Hoffman D.J., Rattner B.A., Burton G.A. Jr, Cairns J. Jr. Handbook of Ecotoxicology. Second Edition:2002;Lewis Publishers, Boca Raton, FL.
50. Khan N., Deschaux P. Role of serotonin in fish immunomodulation. J. Exp. Biol. 200:1997;1833-1838.
51. Khan I.A., Thomas P. Stimulatory effects of serotonin on maturational gonadotropin release in the Atlantic croaker, Micropogonias undulatus. Gen. Comp. Endocrinol. 88:1992;388-396.
52. Khan I.A., Thomas P. Seasonal and daily variations in the plasma gonadotropin II response to a LHRH analog and serotonin in Atlantic craoker (Micropogonias undulatus): evidence for mediation by 5-HT2 receptors. J. Exp. Zool. 269:1994;531-537.
53. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Tech. 36:(6):2002;1202-1211.
54. Lange R., Dietrich D. Environmental risk assessment of pharmaceutical drug substances-conceptual considerations. Toxicol. Lett. 31:2002;97-104.
55. Lanzky P.F., Halling-Sorensen B. The toxic effect of the antibiotic metronidazole on aquatic organisms. Chemosphere. 35:(11):1997;2553-2561.
56. LeBlanc G.A., Campbell P.M., den Besten P., Brown R.P., Chang E.S., Coats J.R., deFur P.L., Dhadialla T., Edwards J., Riddiford L.M., Simpson M.G., Snell T.W., Thorndyke M., Matsumura F. The endocrinology of invertebrates. deFur P.L., Crane M., Ingersoll C.G., Tattersfield L. Endocrine Disruption in Invertebrates: Endocrinology, Testing, and Assessment. 1999;SETAC Press, Pensacola, FL.
57. La Point T.W., Waller W.T. Field assessment in conjunction with whole effluent toxicity testing. Environ. Toxicol. Chem. 19:2000;14-24.
58. Marsh K.E., Foran C.M., Willet K., Brooks B.W. Aquatic resources and human health. Holland M.M., Blood E.R., Shaffer L. Achieving Sustainable Freashwater Systems: A Web of Connections. 2003;65-83 Island Press, New York.
59. McLean, B., 2001. Prozac: A Bitter Pill. Fortune.com, August 13, 2001. http://www.fortune.com/indexw.jhtml?channel=artcol.jhtml&doc_id=203499 (cited 23 June 2002).
60. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A., Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition. 16:2000;843-857.
61. Metcalfe, C., Koenig, B., 2001. A survey of levels of ibuprofen in surface water in the lower Great Lakes. Report No.: Water Quality Centre, Trent University.
62. Metcalfe C.D., Gray M.A., Kiparssos Y. The Japanese medaka (Oryzias latipes): an in vivo model for assessing the impacts of aquatic contaminants on the reproductive success of fish. Rao S.S. Impact Assessment of Hazardous Aquatic Contaminants. 1999;29-52 Lewis Publishers, Boca Raton, FL.
63. Mossner R., Lesch K.P. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12:1998;249-271.
64. Munoz-Bellido J.L., Munoz-Criado S., Garcìa-Rodrìguez J.A. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int. J. Antimicrob. Ag. 14:2000;177-180.
65. Nation J.L. Insect Physiology and Biochemistry. 2002;CRC Press, Boca Raton, FL.
66. Nichols K., Snyder E., Miles-Richardson S., Pierens S., Snyder S., Giesy J.P. Effects of municipal wastewater exposure in situ on the reproductive physiology of the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 18:1999;2001-2012.
67. Nilsson S.N., Sundin L. Gill blood flow control. Comp. Biochem. Physiol. 119A:(1):1998;137-147.
68. NDC Health, 1999. The internet drug index (The top 200 prescriptions of 1998: 1998 US prescriptions based on more than 2.4 billion U.S. prescriptions). http://www.rxlist.com/top200.htm. (Cited 24 June 2002).
69. Pfluger P., Dietrich D.R. Effects on pharmaceuticals in the environment - an overview and principle considerations. Kummerer K. Pharmaceuticals in the Environment. 2001;11-17 Springer-Verlag, Berlin, Germany.
70. Rang H.P., Dale M.M., Ritter J.M., Gardner P. Pharmacology. 1995;590-592 Churchill Livingstone, New York.
71. Ranganathan R., Sawin E.R., Trent C., Horvitz H.R. Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine. J. Neurosci. 21:2001;5871-5884.
72. Richards, S.M., Wilson, C.W., Johnson, D.J., Castle, D.M., Lam, M., Mabury, S.A., Sibley, P.K., Solomon, K., 2003. Effects of pharmaceuticals in aquatic ecosystems. (Submitted for publication).
73. Richardson M.L., Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharmacokin. Pharmacol. 37:1985;1-12.
74. Rossknecht H., Hetzenauer H., Ternes T.A. Pharmaceuticals in Lake Constance. Nachrichten Aus Der Chemie. 49:(2):2001;145-149.
75. Servos, M.R., Bennie, D.T., Starodub, M.E., Orr, J.C., 2002. Pharmaceuticals and personal care products in the environment: a summary of published literature. Report No. 02-309: National Water Research Institute. Burlington, Ontario.
76. Solomon K.R., Baker D.B., Richards R.P., Dixon K.R., Klaine S.J., La Point T.W., Kendall R.J., Giddings J.M., Giesy J.P., Hall L.J. Jr, Williams W.M. Ecological risk assessment of atrazine in North American surface waters. Environ. Toxicol. Chem. 15:1996;31-76.
77. Stan H.J., Heberer T. Pharmaceuticals in the aquatic environment. Analysis. 25:1997;20-23.
78. Stumpf M., Ternes T., Haberer K., Seel P., Baumann W. Determination of drugs in sewage treatment plants and river water. Vom Wasser. 86:1996;291-303.
79. Stumpf M., Ternes T.A., Wilken R.-D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 225:1999;135-141.
80. Suedel B., Rodgers J.H. Jr. Toxicity of fluoranthene to Daphnia magna, Hyalella azteca, Chironomus tentans, and Stylaria lacustris in water-only and whole sediment exposures. Bull. Environ. Contam. Toxicol. 57:1996;132-138.
81. Suter M.J.F., Giger W. Trace determinants of emerging water pollutants: endocrine disruptors, pharmaceuticals, and specialty chemicals. Chimia. 54:(1-2):2000;13-16.
82. Ternes T. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32:(11):1998;3245-3260.
83. Uhler G.C., Huminski P.T., Les F.T., Fong P.P. Cilia-driven rotational behavior in gastropod (Physa elliptica) embryos induced by serotonin and putative serotonin reuptake inhibitors (SSRIs). J. Exp. Zool. 286:(4):2000;414-421.
84. USEPA, 1989. Short-Term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to Freshwater Organisms, 2nd Edition. EPA 600/4-89-001. Environmental Monitoring Systems Laboratory, Cincinnati, OH.
85. USEPA, 1991. Methods for Measuring the Acute Toxicity of Effluents Receiving waters to Freshwater and Marine Organisms, 4th Edition. EPA/600/4-90/027.
86. USEPA, 2000. Methods for Measuring the Toxicity and Bioaccumulation of Sediment-associated Contaminants with Freshwater Invertebrates, 2nd Edition. EPA 600/R-99/064.
87. Velagaleti, R., Robinson, J., 2000. Degradation and depletion of pharmaceutical chemicals in the environment. Abstracts of Papers of the American Chemical Society 219, 51-ENVR.
88. Webb S.F. A data based perspective on the environmental risk assessment of human pharmaceuticals II-aquatic risk characterization. Kummerer K. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. 2001;Springer-Verlag, Berlin.
89. Weston, J.J., Huggett, D.B., Rimoldi, J., Foran, C.M., Stattery, M., 2001. Determination of fluoxetine (Prozac™) and norfluoxetine in the aquatic environment. Annual Meeting of the Society of Environmental Toxicology and Chemistry, Baltimore, MD.
90. Weston, J.J., Foran, C.M., Slattery, M., Brooks, B.W., Huggett, D.B., 2003. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine exposure. (Submitted for publication).
91. Zhang L., Khan I.A., Foran C.M. Characterization of the estrogenic response to genistein in Japanese medaka (Oryzias latipes). Comp. Biochem. Phys. Part C. 132:2002;203-211.